Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

As organizations race to adopt artificial intelligence, the conversation has increasingly shifted from raw model performance ...

Buffer overflow vulnerabilities have driven remote code execution for decades and keep appearing in critical network ...

The latest generation of AI models are such competent coders, engineers and (soon) scientists that many worry they may be ...